Part of the Medical Radiology book series (MEDRAD)


Benign neurofibroma most often occurs in association with von Recklinghausen disease, but may also occur independently. In von Recklinghausen disease sarcomatous changes occur without previous irradiation. Critical location and recurrence are the most common reasons for treatment of benign neurofibroma. Definitive radiation may be used in circumstances such that complete excision is not feasible, or where debulking plus radiation therapy may lead to control, or when excision to any extent is severely limited. High dose radiation therapy is then recommended. The limited literature for this condition is worthy of review prior to considering treatment. The usual proviso for risk-benefit and informed consent should be followed. Seventy-three percent of radiation oncologists in the national survey would not treat neurofibroma.


Soft Tissue Sarcoma Radiation Oncologist Complete Excision Critical Location Previous Irradiation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Tepper JE and Suit HD (1985) The role of radiation therapy in the treatment of sarcoma of soft tissue. Cancer Invest 3: 587–592.PubMedCrossRefGoogle Scholar
  2. 2.
    Smalley SR, Rubin J and Leifermann KM (1984) Neurofibrosarcoma and the sign of Leser-Trelat. Ca 34: 295–298.PubMedGoogle Scholar
  3. 3.
    Greenberg HM, Goebel R, Weichselbaum RR, Greenberger JS, Chaffey JT and Cassady JR (1981) Radiation therapy in the treatment of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 7: 305–310PubMedCrossRefGoogle Scholar
  4. 4.
    Suit HD and Russell WO (1975) Radiation therapy of soft tissue sarcoma. Cancer 36: 759–764.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  1. 1.The Johns Hopkins HospitalBaltimoreUSA
  2. 2.School of MedicineStanford UniversityStanfordUSA

Personalised recommendations